Oklahoma HB 3418: Pharmacy; sale, manufacturing or packaging of dangerous drugs; licensure exceptions; effective date.

Status: Second Reading referred to Health and Human Services Committee then to Appropriations Committee (as of 2020-04-06)

State: Oklahoma · Session: 2020 · Bill: HB 3418

Sponsors: McCortney, McEntire

View Oklahoma HB 3418 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.